Medication info

Mega Alend Tablet (Sodium Alendronate Trihydrate)

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Sodium Alendronate Trihydrate›91.37mg / 1 tablet
Manufacturer / importer
L&C Bio Co., Ltd.
Appearance
White oval tablet
Packaging
4 tablets (4 tablets/PTP packaging (AluAlu)x1)
Approval status
Approval withdrawn

MFDS item code 202001654 · Approved 2020.03.10

This product's status changed to Approval withdrawn on 2024.09.04. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of osteoporosis in postmenopausal women and men
Who takes it
Adults
Adult dose
○ Take 70 mg of alendronic acid once weekly in the morning with a sufficient amount of water, at least 30 minutes before consuming food, beverages, or other medicines (see Precautions). ○ Other beverages or food, including mineral water and barley tea, and medicines may decrease the absorption of this medicine (see Drug Interactions). Consuming food within 30 minutes after taking this medicine, or at the same time, may reduce its absorption into the body and decrease its effectiveness. Take this medicine as soon as you get up in the morning and swallow it with a sufficient amount of water (170 ∼ 230 mL) to help the medicine reach the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking this medicine and until after your first food intake. Do not take this medicine at bedtime or before getting up in the morning. Failure to follow these directions may increase the risk of esophageal adverse reactions (see Warnings and Precautions). Patients with inadequate dietary intake of calcium and vitamin D should take supplements (see Precautions). ○ The appropriate duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. In patients at low risk of fracture, discontinuation should be considered after 3 ∼ 5 years of treatment. Patients who discontinue treatment should be reassessed regularly for fracture risk. ○ If you forget to take a dose on the scheduled day, take 70 mg the next morning, then resume taking it on the originally scheduled day and continue regularly once weekly thereafter. Do not take 2 tablets on the same day.

Ingredients

Manufacturer
L&C Bio Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women and men

  • Osteoporosis
View approved original text

This medication is used for the treatment of osteoporosis in postmenopausal women and men.

How to take

Adult dose

○ Take 70 mg of alendronic acid once weekly in the morning with a sufficient amount of water, at least 30 minutes before consuming food, beverages, or other medicines (see Precautions). ○ Other beverages or food, including mineral water and barley tea, and medicines may decrease the absorption of this medicine (see Drug Interactions). Consuming food within 30 minutes after taking this medicine, or at the same time, may reduce its absorption into the body and decrease its effectiveness. Take this medicine as soon as you get up in the morning and swallow it with a sufficient amount of water (170 ∼ 230 mL) to help the medicine reach the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking this medicine and until after your first food intake. Do not take this medicine at bedtime or before getting up in the morning. Failure to follow these directions may increase the risk of esophageal adverse reactions (see Warnings and Precautions). Patients with inadequate dietary intake of calcium and vitamin D should take supplements (see Precautions). ○ The appropriate duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. In patients at low risk of fracture, discontinuation should be considered after 3 ∼ 5 years of treatment. Patients who discontinue treatment should be reassessed regularly for fracture risk. ○ If you forget to take a dose on the scheduled day, take 70 mg the next morning, then resume taking it on the originally scheduled day and continue regularly once weekly thereafter. Do not take 2 tablets on the same day.

Precautions

This medication may irritate the gastrointestinal tract, so those with diseases of the esophagus or stomach should exercise extra caution. Problems such as esophagitis or esophageal ulcer may occur, and in severe cases, can lead to esophageal obstruction or perforation. If unusual symptoms appear, discontinue use immediately and consult a doctor. When taking this medication, it must be taken with a sufficient amount of water, and one should not lie down for at least 30 minutes after taking it. It is important to maintain a time gap between taking food or other medications before and after taking this medicine. Individuals with esophageal problems, those who cannot sit or stand for over 30 minutes, patients with hypocalcemia or severe renal impairment, and women who are pregnant or breastfeeding should not take this medication. Additionally, this drug requires supplementation if there is a deficiency of calcium and vitamin D, and prolonged use may cause bone or muscle pain; thus, if symptoms persist, consult a healthcare provider. During the use of this medication, care should be taken not to use calcium supplements or antacids, and any ongoing medications should be discussed due to potential interactions. Women who are pregnant or may become pregnant and nursing mothers should not take this drug, and the safety in children or adolescents under 18 has not been established. Elderly individuals can take this medication, but caution is advisable considering age-related sensitivity. In the case of overdose, gastrointestinal irritation symptoms may appear, and one should visit a medical institution immediately; do not induce vomiting and keep the patient upright. Finally, this medication should be kept out of the reach of children, and it is better not to transfer it to another container.

Side effects

esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, bleeding, gastric ulcer, duodenal ulcer, abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, acid reflux, vomiting, dysphagia, abdominal distension, gastritis, musculoskeletal pain, muscle spasms, headache, dizziness, taste disturbance, rash, erythema, anastomotic ulcer, hives, angioedema, myalgia, fatigue, asthenia, fever, symptoms of hypocalcemia, peripheral edema, oropharyngeal ulcer, osteonecrosis of the jaw, joint swelling, low-energy fractures of the femoral neck and other bones, dizziness, itching, hair loss, mucous membrane pemphigoid, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, cholesteatoma of the external ear canal, melena

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture; therefore, it should be stored in a tightly sealed container. It is best kept in a cool place between 15 to 30 degrees Celsius.

Appearance and packaging

Appearance

White oval tablet

Package unit

4 tablets (4 tablets/PTP packaging (AluAlu)x1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.